These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 987188)

  • 1. [Studies on the syntheses of sulfur containing pyrimido [5,4-d]pyrimidine derivatives. I. Syntheses of pyrimido [5,4-D]pyrimidine derivatives possessing methylsulfonyl or sulfonamide group at 2-position].
    Imai K; Ishida T; Horiguchi H; Ozasa T; Ohono M
    Yakugaku Zasshi; 1976 May; 96(5):578-85. PubMed ID: 987188
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on the synthesis of sulfur containing pyrimido [5,4-d]pyrimidine derivatives. II. Syntheses and rearrangement of 2-methylsulfonyl pyrimido[5,4-d]pyrimidine-6-sulfonamide derivatives].
    Imai K; Ishida T; Ozasa T; Kawahara S; Murakami M
    Yakugaku Zasshi; 1976 May; 96(5):586-92. PubMed ID: 987189
    [No Abstract]   [Full Text] [Related]  

  • 3. Potentiation of the coronary vasodilator effect of norepinephrine by 2,6-bis (diethanolamino)-4,8-dipiperidino-pyrimido (5,4-d) pyrimidine (dipyridamole).
    Hashimoto K; Sano N
    Tohoku J Exp Med; 1968 Oct; 96(2):207-8. PubMed ID: 5708523
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis and antimicrobial properties of 3-sulfonyl-1,2,3,4-tetrahydropyrimido [4,5-d] pyrimidines.
    Cieplik J; Pluta J; Gubrynowicz O
    Boll Chim Farm; 2004 Nov; 143(9):321-8. PubMed ID: 15881809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on cardiovascular agents. 6. Synthesis and coronary vasodilating and antihypertensive activities of 1,2,4-triazolo[1,5-a]pyrimidines fused to heterocyclic systems.
    Sato Y; Shimoji Y; Fujita H; Nishino H; Mizuno H; Kobayashi S; Kumakura S
    J Med Chem; 1980 Aug; 23(8):927-37. PubMed ID: 7401118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of platelet aggregation in vivo: IV Effect of pyrimido-pyrimidine derivatives.
    Ambrus JL; Ambrus CM; Gastpar H; Thurber L; Miller R; Fretwell B; Lane KP
    J Med; 1977; 8(5):287-94. PubMed ID: 412904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of some pyrimido-pyrimidine derivatives on blood coagulation and platelet aggregation.
    Bédi J; Blaskó G; Pálos LA
    Arzneimittelforschung; 1979; 29(9):1405-8. PubMed ID: 583250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosine kinase inhibitors. 12. Synthesis and structure-activity relationships for 6-substituted 4-(phenylamino)pyrimido[5,4-d]pyrimidines designed as inhibitors of the epidermal growth factor receptor.
    Rewcastle GW; Bridges AJ; Fry DW; Rubin JR; Denny WA
    J Med Chem; 1997 Jun; 40(12):1820-6. PubMed ID: 9191958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syntheses and properties of selected derivatives of pyrimido[5,4-e]-1,3-thiazine and pyrimido[4,5-d]pyrimidine.
    Malinka W; Zawisza T; Zajac HE
    Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):487-97. PubMed ID: 2517913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of norepinephrine and adenosine in the renal circulation by 2,6-bis (diethanolamino)-4,8-dipiperidino-pyrimido (5,4-d) pyrimidine (dipyridamole) treatment (preliminary report).
    Yasuda K; Satoh S; Taira N; Hashimoto K
    Tohoku J Exp Med; 1968 Oct; 96(2):161-4. PubMed ID: 5708519
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pyrimidine derivatives. VI. Studies on the syntheses of orotic acid, uracil and pyrimido(5,4-d)pyrimidine derivatives].
    Okui K; Mizoguchi M
    Yakugaku Zasshi; 1972 Jul; 92(7):785-95. PubMed ID: 4676215
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis and QSAR studies of pyrimido[4,5-d]pyrimidine-2,5-dione derivatives as potential antimicrobial agents.
    Sharma P; Rane N; Gurram VK
    Bioorg Med Chem Lett; 2004 Aug; 14(16):4185-90. PubMed ID: 15261267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antibacterial properties of pyrimidine derivatives.
    Cieplik J; Stolarczyk M; Pluta J; Gubrynowicz O; Bryndal I; Lis T; Mikulewicz M
    Acta Pol Pharm; 2015; 72(1):53-64. PubMed ID: 25850201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synthesis and antibacterial activity of 3-alkyl derivatives of some pyrimido[4,5-d] pyrimidine.
    Cieplik J; Pluta J; Gubrynowicz O
    Acta Pol Pharm; 2003; 60(6):487-92. PubMed ID: 15080598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemorrheologic effects of pyrimido-pyrimidine derivatives.
    Ambrus JL; Stadler I; Kulaylat M; Koreshi A; Akhtar S
    J Med; 1996; 27(1-2):21-32. PubMed ID: 8863175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modifications and structure-activity relationships at the 2-position of 4-sulfonamidopyrimidine derivatives as potent endothelin antagonists.
    Morimoto H; Shimadzu H; Hosaka T; Kawase Y; Yasuda K; Kikkawa K; Yamauchi-Kohno R; Yamada K
    Bioorg Med Chem Lett; 2002 Jan; 12(1):81-4. PubMed ID: 11738578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel hepatitis C virus replicon inhibitors: synthesis and structure-activity relationships of fused pyrimidine derivatives.
    Krueger AC; Madigan DL; Beno DW; Betebenner DA; Carrick R; Green BE; He W; Liu D; Maring CJ; McDaniel KF; Mo H; Molla A; Motter CE; Pilot-Matias TJ; Tufano MD; Kempf DJ
    Bioorg Med Chem Lett; 2012 Mar; 22(6):2212-5. PubMed ID: 22342631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrido[2,3-d]pyrimidin-4(3H)-one derivatives and 1,2,3,4-tetrahydro- pyrido[2,3-d]pyrimidine derivatives: synthesis and in vitro study of their activity against platelet aggregation.
    Hou G; Gravier D; Casadebaig F; Dupin JP; Bernard H; Boisseau M
    Pharmazie; 1995 Nov; 50(11):719-22. PubMed ID: 8570668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of some pyrimidine, pyrimido[2,1-b][1,3]thiazine and thiazolo[3,2-a]pyrimidine derivatives.
    Sayed HH; Shamroukh AH; Rashad AE
    Acta Pharm; 2006 Jun; 56(2):231-44. PubMed ID: 16613728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chiral pyrrolo[2,3-d]pyrimidine and pyrimido[4,5-b]indole derivatives: structure-activity relationships of potent, highly stereoselective A1-adenosine receptor antagonists.
    Müller CE; Geis U; Grahner B; Lanzner W; Eger K
    J Med Chem; 1996 Jun; 39(13):2482-91. PubMed ID: 8691445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.